Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3892/mco.2017.1130 http://scihub22266oqcxt.onion/10.3892/mco.2017.1130 C5403349!5403349!28451430     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Mol+Clin+Oncol 2017 ; 6 (3): 441-3 Nephropedia Template TP {{tp|p=28451430|t=2017. Efficacy of metformin for advanced-stage endometrial cancer: A case report |pdf=|usr=}}{{28451430}} gab.com Text Efficacy of metformin for advanced-stage endometrial cancer: A case report JO: Mol Clin Oncol http://www.kidney.de/pget.php?&tw=1&pmid=28451430 #FOAvip The paradigm of obesity, diabetes mellitus and insulin resistance possibly plays a critical role in the pathogenesis of endometrial cancer (EC). Impaired glucose tolerance and insulin resistance may play a direct or facilitating role in the neoplastic transformation of the endometrium, whereas antidiabetic therapy, particularly with metformin, has been suggested to inhibit EC progression. We herein present the case of a patient with EC who received metformin monotherapy due to complications after undergoing surgery. At 45 months after the introduction of metformin treatment, the patient had no complaints and continued receiving metformin without signs of tumor recurrence. As metformin is widely used among diabetic patients and in ongoing clinical trials in cancer patients, the aforementioned results deserve further clinical investigation. Twit Text FOAVip Efficacy of metformin for advanced-stage endometrial cancer: A case report ????Mol Clin Oncol http://www.kidney.de/pget.php?&tw=1&pmid=28451430 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28451430 #FOAvip English Wikipedia <ref>{{Cite pmid|28451430}}</ref> Efficacy of metformin for advanced-stage endometrial cancer: A case report #MMPMID28451430 Sato E; Nakayama K; Nakamura K; Ishikawa N; Ishikawa M; Minamoto T; Ishibashi T; Kyo S Mol Clin Oncol 2017[Mar]; 6 (3): 441-3 PMID28451430show ga The paradigm of obesity, diabetes mellitus and insulin resistance possibly plays a critical role in the pathogenesis of endometrial cancer (EC). Impaired glucose tolerance and insulin resistance may play a direct or facilitating role in the neoplastic transformation of the endometrium, whereas antidiabetic therapy, particularly with metformin, has been suggested to inhibit EC progression. We herein present the case of a patient with EC who received metformin monotherapy due to complications after undergoing surgery. At 45 months after the introduction of metformin treatment, the patient had no complaints and continued receiving metformin without signs of tumor recurrence. As metformin is widely used among diabetic patients and in ongoing clinical trials in cancer patients, the aforementioned results deserve further clinical investigation. äEfficacy of metformin for advanced-stage endometrial cancer: A case re(epmc).pdf DeepDyve Pubget Overpricing